To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Clinical trial NCT01725126 · COMPLETED
Trial details
- NCT number
- NCT01725126
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-10
- Primary completion
- 2013-09-12
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.